new data in myelodysplastic syndromes
Published 4 years ago • 417 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:43
novel therapies in the future of mds treatment
-
4:01
the latest genomic updates in the field of mds
-
2:07
emerging targeted treatments for mds
-
3:10
the role of ngs in mds diagnosis
-
5:22
magrolimab azacitidine in mds and aml
-
17:04
mds - myelodysplastic syndrome
-
4:48
managing and treating mds
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds
-
1:22
key advances in mds management
-
1:19
the promise of precision medicine in mds
-
1:01
evolving role of next-generation sequencing in mds
-
3:37
progress in the categorization and treatment of lr-mds
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
1:17
exciting novel treatments being developed for mds
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
2:42
final results of the dart4mm study of daratumumab for mrd eradication in myeloma
-
1:03
late effect surveillance following allosct: the publication of new guidelines